Concepts (171)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Absorbable Implants | 3 | 2019 | 191 | 1.36 | Why? |
| Drug-Eluting Stents | 3 | 2019 | 562 | 1.04 | Why? |
| Percutaneous Coronary Intervention | 4 | 2019 | 3646 | 0.74 | Why? |
| Coronary Artery Disease | 4 | 2021 | 2570 | 0.71 | Why? |
| Darunavir | 2 | 2020 | 477 | 0.69 | Why? |
| Hirudins | 1 | 2017 | 75 | 0.67 | Why? |
| Heart Aneurysm | 1 | 2017 | 46 | 0.65 | Why? |
| Coronary Circulation | 1 | 2017 | 188 | 0.58 | Why? |
| Endocarditis, Bacterial | 1 | 2020 | 344 | 0.58 | Why? |
| Myocardium | 2 | 2017 | 2323 | 0.57 | Why? |
| Staphylococcus aureus | 1 | 2020 | 844 | 0.52 | Why? |
| Hydroxychloroquine | 4 | 2021 | 12447 | 0.51 | Why? |
| Mediastinal Emphysema | 1 | 2020 | 519 | 0.50 | Why? |
| Heart Conduction System | 1 | 2016 | 266 | 0.49 | Why? |
| Shock, Cardiogenic | 1 | 2019 | 700 | 0.48 | Why? |
| Angioplasty, Balloon, Coronary | 1 | 2016 | 365 | 0.47 | Why? |
| Myocardial Infarction | 2 | 2019 | 3361 | 0.45 | Why? |
| Pulmonary Embolism | 2 | 2021 | 4775 | 0.43 | Why? |
| Staphylococcal Infections | 1 | 2020 | 1099 | 0.43 | Why? |
| Electrocardiography | 3 | 2020 | 3957 | 0.42 | Why? |
| Long QT Syndrome | 1 | 2020 | 1047 | 0.42 | Why? |
| Scleroderma, Systemic | 1 | 2017 | 583 | 0.41 | Why? |
| Heart Ventricles | 1 | 2017 | 1139 | 0.35 | Why? |
| Glucocorticoids | 2 | 2021 | 4431 | 0.35 | Why? |
| Frailty | 1 | 2019 | 1432 | 0.34 | Why? |
| Prosthesis Design | 3 | 2019 | 594 | 0.33 | Why? |
| Ritonavir | 2 | 2020 | 4212 | 0.31 | Why? |
| Fibrinolytic Agents | 1 | 2017 | 1702 | 0.30 | Why? |
| Antithrombins | 2 | 2020 | 353 | 0.29 | Why? |
| Azithromycin | 1 | 2020 | 3943 | 0.29 | Why? |
| Polymers | 2 | 2017 | 507 | 0.24 | Why? |
| Heart Failure | 2 | 2020 | 6638 | 0.24 | Why? |
| Italy | 13 | 2021 | 38444 | 0.23 | Why? |
| Cardiovascular Diseases | 3 | 2020 | 11497 | 0.22 | Why? |
| Sodium Potassium Chloride Symporter Inhibitors | 1 | 2020 | 49 | 0.21 | Why? |
| Computed Tomography Angiography | 2 | 2021 | 2153 | 0.21 | Why? |
| Hospital Mortality | 8 | 2021 | 22087 | 0.20 | Why? |
| Valsartan | 1 | 2020 | 206 | 0.19 | Why? |
| Biphenyl Compounds | 1 | 2020 | 249 | 0.19 | Why? |
| Aminobutyrates | 1 | 2020 | 142 | 0.19 | Why? |
| Mineralocorticoid Receptor Antagonists | 1 | 2020 | 203 | 0.19 | Why? |
| Dabigatran | 1 | 2020 | 204 | 0.18 | Why? |
| Heparin | 3 | 2021 | 2600 | 0.17 | Why? |
| Tetrazoles | 1 | 2020 | 262 | 0.17 | Why? |
| Aged | 19 | 2021 | 215776 | 0.17 | Why? |
| Risk Factors | 12 | 2021 | 71621 | 0.17 | Why? |
| Pneumonia, Viral | 9 | 2021 | 243684 | 0.17 | Why? |
| Adrenergic beta-Antagonists | 1 | 2020 | 465 | 0.16 | Why? |
| Coronavirus Infections | 8 | 2020 | 253789 | 0.16 | Why? |
| Echocardiography, Transesophageal | 1 | 2020 | 447 | 0.16 | Why? |
| Vascular Calcification | 1 | 2021 | 396 | 0.16 | Why? |
| Treatment Outcome | 7 | 2021 | 51732 | 0.16 | Why? |
| Betacoronavirus | 8 | 2020 | 204454 | 0.16 | Why? |
| Cardiologists | 1 | 2021 | 366 | 0.15 | Why? |
| Thiazoles | 1 | 2020 | 496 | 0.14 | Why? |
| Factor Xa Inhibitors | 1 | 2020 | 490 | 0.14 | Why? |
| Troponin | 1 | 2021 | 1058 | 0.14 | Why? |
| Pyridones | 1 | 2020 | 738 | 0.14 | Why? |
| Withholding Treatment | 1 | 2020 | 798 | 0.14 | Why? |
| Coronary Angiography | 3 | 2021 | 2275 | 0.14 | Why? |
| Pyridines | 1 | 2020 | 680 | 0.13 | Why? |
| Blood Pressure Determination | 1 | 2017 | 450 | 0.13 | Why? |
| Natriuretic Peptide, Brain | 1 | 2020 | 1215 | 0.13 | Why? |
| Humans | 29 | 2021 | 930598 | 0.13 | Why? |
| Quarantine | 1 | 2020 | 18418 | 0.13 | Why? |
| Echocardiography | 3 | 2020 | 3661 | 0.12 | Why? |
| Magnetic Resonance Imaging, Cine | 1 | 2017 | 669 | 0.12 | Why? |
| Time Factors | 4 | 2020 | 31397 | 0.12 | Why? |
| Male | 18 | 2021 | 367725 | 0.11 | Why? |
| Dilatation, Pathologic | 1 | 2011 | 78 | 0.11 | Why? |
| Heparin, Low-Molecular-Weight | 1 | 2021 | 1731 | 0.11 | Why? |
| Telephone | 1 | 2020 | 1705 | 0.11 | Why? |
| Hospitalization | 3 | 2021 | 54280 | 0.11 | Why? |
| Acute Disease | 2 | 2021 | 6029 | 0.11 | Why? |
| Drug Combinations | 1 | 2020 | 3852 | 0.10 | Why? |
| Recurrence | 1 | 2020 | 3675 | 0.10 | Why? |
| Stroke Volume | 1 | 2020 | 2153 | 0.10 | Why? |
| Continuity of Patient Care | 1 | 2020 | 1574 | 0.10 | Why? |
| Stents | 1 | 2017 | 916 | 0.10 | Why? |
| Multiple Organ Failure | 1 | 2020 | 1724 | 0.10 | Why? |
| Female | 16 | 2021 | 380317 | 0.10 | Why? |
| Enzyme Inhibitors | 1 | 2020 | 1881 | 0.10 | Why? |
| Anticoagulants | 3 | 2021 | 9563 | 0.10 | Why? |
| Pyrazoles | 1 | 2020 | 1791 | 0.10 | Why? |
| Tomography, X-Ray Computed | 3 | 2020 | 25144 | 0.10 | Why? |
| Randomized Controlled Trials as Topic | 2 | 2019 | 10649 | 0.10 | Why? |
| Aged, 80 and over | 9 | 2021 | 88759 | 0.10 | Why? |
| Comorbidity | 4 | 2020 | 34796 | 0.09 | Why? |
| Chronic Disease | 2 | 2020 | 5139 | 0.09 | Why? |
| Antimalarials | 1 | 2021 | 2505 | 0.09 | Why? |
| Ambulatory Care Facilities | 1 | 2020 | 2063 | 0.09 | Why? |
| Middle Aged | 14 | 2021 | 270681 | 0.09 | Why? |
| Hemorrhage | 2 | 2020 | 3013 | 0.09 | Why? |
| Incidence | 2 | 2021 | 25622 | 0.09 | Why? |
| Hypertrophy, Left Ventricular | 1 | 2011 | 219 | 0.09 | Why? |
| Denmark | 1 | 2016 | 2654 | 0.09 | Why? |
| Thrombophilia | 1 | 2021 | 1935 | 0.09 | Why? |
| Anti-Bacterial Agents | 2 | 2020 | 10083 | 0.09 | Why? |
| Aorta | 1 | 2011 | 355 | 0.09 | Why? |
| Insulin | 1 | 2017 | 1316 | 0.09 | Why? |
| Blood Pressure | 2 | 2017 | 2198 | 0.09 | Why? |
| Follow-Up Studies | 2 | 2017 | 17020 | 0.09 | Why? |
| Retrospective Studies | 8 | 2021 | 105322 | 0.08 | Why? |
| Recombinant Proteins | 1 | 2017 | 3786 | 0.08 | Why? |
| Cause of Death | 1 | 2020 | 4823 | 0.08 | Why? |
| Peptide Fragments | 1 | 2017 | 2075 | 0.08 | Why? |
| Age Factors | 4 | 2020 | 21039 | 0.08 | Why? |
| Evidence-Based Medicine | 1 | 2019 | 3228 | 0.08 | Why? |
| Disease Progression | 2 | 2020 | 13580 | 0.07 | Why? |
| Survival Rate | 1 | 2019 | 9206 | 0.07 | Why? |
| Fibrin Fibrinogen Degradation Products | 1 | 2021 | 5993 | 0.07 | Why? |
| Renin-Angiotensin System | 1 | 2020 | 3661 | 0.07 | Why? |
| Hypoglycemic Agents | 1 | 2017 | 2165 | 0.07 | Why? |
| Pandemics | 8 | 2020 | 389249 | 0.07 | Why? |
| Machine Learning | 1 | 2020 | 4395 | 0.07 | Why? |
| ST Elevation Myocardial Infarction | 1 | 2020 | 3051 | 0.06 | Why? |
| Coronary Vessels | 2 | 2021 | 914 | 0.06 | Why? |
| Magnetic Resonance Imaging | 1 | 2020 | 6551 | 0.06 | Why? |
| Sepsis | 1 | 2020 | 3517 | 0.06 | Why? |
| Cardiac Surgical Procedures | 1 | 2017 | 1931 | 0.06 | Why? |
| Hospitals, University | 1 | 2016 | 4173 | 0.06 | Why? |
| Prevalence | 3 | 2020 | 25773 | 0.06 | Why? |
| Prognosis | 3 | 2021 | 32490 | 0.06 | Why? |
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2020 | 5277 | 0.06 | Why? |
| Risk Assessment | 3 | 2020 | 25439 | 0.06 | Why? |
| Coinfection | 1 | 2020 | 6820 | 0.05 | Why? |
| Partial Pressure | 1 | 2020 | 279 | 0.05 | Why? |
| Research Design | 1 | 2016 | 5830 | 0.05 | Why? |
| Aorta, Thoracic | 1 | 2021 | 271 | 0.05 | Why? |
| Antiviral Agents | 2 | 2020 | 41703 | 0.04 | Why? |
| Blood Gas Analysis | 1 | 2020 | 893 | 0.04 | Why? |
| Survival Analysis | 2 | 2021 | 7592 | 0.04 | Why? |
| Aortic Diseases | 1 | 2021 | 362 | 0.04 | Why? |
| Calcium | 1 | 2021 | 708 | 0.04 | Why? |
| Thrombosis | 1 | 2017 | 7504 | 0.04 | Why? |
| Coronary Restenosis | 1 | 2017 | 153 | 0.04 | Why? |
| Troponin T | 1 | 2020 | 771 | 0.04 | Why? |
| Diabetes Mellitus | 1 | 2017 | 8207 | 0.03 | Why? |
| Protective Factors | 1 | 2020 | 1720 | 0.03 | Why? |
| Aortic Valve | 1 | 2021 | 664 | 0.03 | Why? |
| Glomerular Filtration Rate | 1 | 2020 | 1262 | 0.03 | Why? |
| Delivery of Health Care | 1 | 2020 | 15909 | 0.03 | Why? |
| Cluster Analysis | 1 | 2021 | 3001 | 0.03 | Why? |
| Administration, Oral | 1 | 2020 | 2340 | 0.03 | Why? |
| Drug Interactions | 1 | 2020 | 1653 | 0.03 | Why? |
| Severity of Illness Index | 4 | 2021 | 48226 | 0.03 | Why? |
| Troponin I | 1 | 2020 | 1298 | 0.03 | Why? |
| United States | 1 | 2019 | 46150 | 0.03 | Why? |
| Drug Monitoring | 1 | 2020 | 1408 | 0.03 | Why? |
| Coronary Thrombosis | 1 | 2017 | 433 | 0.03 | Why? |
| Body Surface Area | 1 | 2011 | 50 | 0.03 | Why? |
| Heart | 1 | 2021 | 1791 | 0.03 | Why? |
| Lung | 1 | 2020 | 31049 | 0.03 | Why? |
| Multivariate Analysis | 1 | 2020 | 5440 | 0.02 | Why? |
| Hypertension | 1 | 2011 | 8895 | 0.02 | Why? |
| Proportional Hazards Models | 1 | 2020 | 6543 | 0.02 | Why? |
| Blood Coagulation | 1 | 2021 | 2768 | 0.02 | Why? |
| Kaplan-Meier Estimate | 1 | 2017 | 4260 | 0.02 | Why? |
| Platelet Aggregation Inhibitors | 1 | 2017 | 1671 | 0.02 | Why? |
| Predictive Value of Tests | 1 | 2021 | 9537 | 0.02 | Why? |
| Lopinavir | 1 | 2020 | 4308 | 0.02 | Why? |
| Patient Safety | 1 | 2020 | 4885 | 0.02 | Why? |
| Adult | 3 | 2020 | 244371 | 0.02 | Why? |
| C-Reactive Protein | 1 | 2020 | 7972 | 0.02 | Why? |
| Adrenal Cortex Hormones | 1 | 2020 | 6537 | 0.02 | Why? |
| Length of Stay | 1 | 2020 | 11042 | 0.02 | Why? |
| Cross-Sectional Studies | 2 | 2020 | 53120 | 0.01 | Why? |
| Registries | 1 | 2017 | 12327 | 0.01 | Why? |
| Prospective Studies | 1 | 2017 | 43301 | 0.01 | Why? |
| Adolescent | 1 | 2020 | 86841 | 0.01 | Why? |
| Young Adult | 1 | 2020 | 93724 | 0.01 | Why? |
Danzi's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(171)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(331)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_